Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   33    
Direct Shares   1,028,565    

Indirect Shares

   243,774,473      
Direct Value   $74,412,006    

Indirect Value

   $16,676,232,797      
Total Shares   244,803,038      
Total Value   $16,750,644,803      


Incyte Corp $32,589,847 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,254,997 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,499,117 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $285,967 Incyte Corp $32,589,847 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,254,997 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,499,117 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $285,967
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2021-06-22 205,752 2021-06-22 38,452,877    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
* Premium Members only  

Records found :    496         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 14 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ACGN Aceragen, Inc Director   –       •      –    2017-10-02 4 A $2.28 $61,868 I/I 27,135 154,498 0 -
RYTM Rhythm Pharmaceuticals, I... Former 10% owner   –       –      –    2017-10-05 4 B $17.00 $15,045,000 I/I 885,000 1,878,242 0.01 -
RYTM Rhythm Pharmaceuticals, I... Former 10% owner   –       –      –    2017-10-05 4 A $0.00 $0 I/I 1,164,020 1,081,051 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2017-10-13 4 D $35.40 $1,963,178 I/I (55,457) 23,708,408 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2017-10-13 4 OE $1.38 $1,968,694 I/I 1,426,590 23,763,865 0 -
ACGN Aceragen, Inc Director   –       •      –    2017-10-26 4 B $1.50 $12,000,000 I/I 8,000,000 16,557,473 2.1 -
MRTX Mirati Therapeutics, Inc. 10% Owner   –       –       •   2017-11-08 4 OE $7.86 $2,202,867 I/I 280,263 35,999 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2017-11-27 4 OE $1.38 $54,342 I/I 39,378 491,918 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2017-11-27 4 D $28.00 $54,348 I/I (1,941) 489,977 0 -
INCY Incyte Corp Director   –       •       •   2017-12-29 4 A $94.71 $56,826 I/I 600 789,778 0 -
ACGN Aceragen, Inc Director   –       •      –    2018-01-02 4 A $2.21 $61,878 I/I 27,999 163,831 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2018-01-17 4 S $8.63 $2,247,910 I/I (260,600) 66,815 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2018-01-18 4 S $8.12 $2,635,768 I/I (324,774) 62,267 0 -
BGNE Beigene Ltd Director   –       •       •   2018-01-18 4 B $101.00 $199,999,998 I/I 1,980,198 5,121,404 2.25 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2018-01-19 4 S $7.91 $2,336,217 I/I (295,361) 58,131 0 -
ACGN Aceragen, Inc Director   –       •       •   2018-03-15 4 OE $0.47 $9,548,674 I/I 20,316,327 602,867 0 -
NVTA Invitae Corp 10% Owner   –       –       •   2018-03-28 4 B $4.50 $5,000,000 I/I 1,111,111 7,480,182 1.5 -
INCY Incyte Corp Director   –       •       •   2018-03-29 4 A $83.33 $56,998 I/I 684 790,006 0 -
ACGN Aceragen, Inc Director   –       •      –    2018-04-02 4 A $1.62 $64,876 I/I 40,047 616,216 0 -
SGEN Seagen Inc Director   –       •       •   2018-04-30 4 B $50.90 $31,816,925 I/I 623,136 44,978,471 2.25 -
SGEN Seagen Inc Director   –       •       •   2018-05-01 4 OE $10.08 $201,600 I/I 20,000 44,988,471 0 -
SGEN Seagen Inc Director   –       •       •   2018-05-01 4 B $51.14 $15,764,736 I/I 306,917 45,295,388 2.25 -
SGEN Seagen Inc Director   –       •       •   2018-05-02 4 B $51.88 $3,676,836 I/I 69,947 45,365,335 2.25 -
INCY Incyte Corp Director   –       •       •   2018-05-02 4 OE $9.92 $595,200 I/I 60,000 810,006 0 -
SGEN Seagen Inc Director   –       •       •   2018-05-04 4 B $52.68 $10,775,582 I/I 204,537 45,569,872 2.25 -
  496  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14  15   16   17   18   19   20      
  Page 14 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us